Vialwirebiotech, curated
November 21, 2026, 5:44 PM
July 6, 2026
- 10:45 AM · BioPharma Dive10:45 AMGene editing developer Scribe plots an IPO — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMAscletis submits INDs for ASC-36 and ASC-36_35 for obesity — BioWorld
- 6:05 AM · Pharmaceutical Technology6:05 AMRoche pens $490m Astex breast cancer license deal — Pharmaceutical Technology
- 4:56 AM · Pharmaceutical Technology4:56 AMBesins Healthcare boosts drug delivery portfolio with UniD deal — Pharmaceutical Technology
- 4:02 AM · FT — Pharmaceuticals4:02 AMNovartis to buy UK biotech in $1.5bn deal — FT — Pharmaceuticals
- 2:58 AM · Bloomberg — Technology2:58 AMNovartis to Buy Cancer-Drug Firm Myricx for Up to $1.5 Billion — Bloomberg — Technology